Lars Sorensen
Appearances
The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
It's difficult for me to pass judgment on. I think it's about on par.
The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
So I think both companies benefit from this very intense competition.
The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
And so I only welcome it. I would have been more worried if we didn't have competition because then there's always... the risks that complacency sets in.